XML 26 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock Options
6 Months Ended
Mar. 31, 2017
Stock Options [Abstract]  
STOCK OPTIONS
9.STOCK OPTIONS

 

For the period ended March 31, 2017, the Company recorded share-based compensation expense related to stock options in the amount of $2,314 (September 30, 2016 – $237,971) on the stock options that were previously granted. As of March 31, 2017, there was no remaining unrecognized compensation cost related to option awards. Compensation expense is based upon straight-line depreciation of the grant-date fair value over the vesting period of the underlying unit option.

 

   Shares Underlying
Options Outstanding
  Shares Underlying
Options Exercisable
 
 Range of Exercise Price Shares Underlying Options Outstanding  Weighted Average Remaining Contractual Life  Weighted Average Exercise Price  Shares Underlying Options Exercisable  Weighted Average Exercise Price 
                 
 $0.05 at March 31, 2017  3,450,000   1.22   0.05   3,450,000   0.05 
 $0.30 at March 31, 2017  250,000   1.58   0.30   250,000   0.30 
 $0.34 at March 31, 2017  450,000   1.68   0.34   450,000   0.34 
 $0.38 at March 31, 2017  6,780,000   2.47   0.38   6,780,000   0.38 
 $0.23 at March 31, 2017  600,000   2.63   0.23   600,000   0.23 
    11,530,000   2.06  $0.27   11,530,000  $0.27 

 

The aggregate intrinsic value of exercisable options as of March 31, 2017, was $Nil (September 30, 2016 - $Nil).

 

The following is a summary of stock option activity as at March 31, 2017:

 

   Number of Underlying Shares  Weighted Average Exercise Price  Weighted Average Fair Market Value 
           
 Balance, September 30, 2016  11,530,000  $0.27  $0.22 
              
 Balance, March 31, 2017  11,530,000  $0.27  $0.22 
              
 Exercisable, March 31, 2017  11,530,000  $0.27  $0.22 

 

There were no remaining unvested stock options outstanding as of March 31, 2017 (September 30, 2016 –200,000).